TuesdayOct 20, 2026 3:43 pm

QualityStocksNewsBreaks – SS Innovations International Inc. (NASDAQ: SSII) Unveils SSi Mantra 3.0 at Kings Hospital Colombo

SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, is expanding its international footprint with the launch of Sri Lanka’s first robotic cardiac surgery program at Kings Hospital Colombo, powered by its SSi Mantra 3.0 surgical robotic system. The program began with a robotic-assisted left internal mammary artery takedown performed by company founder and Chairman Dr. Sudhir Srivastava alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva, and the hospital reportedly completed more than 25 robotic procedures within the first three weeks. The launch adds to SS Innovations’ international expansion as the company reported 224 cumulative SSi Mantra installations…

Continue Reading

TuesdayOct 20, 2026 3:14 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Scales GelrinC Manufacturing Amidst Development Progress

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel technology, designed to promote the regeneration of durable, natural-like cartilage in patients with painful knee cartilage injuries. The cell-free, off-the-shelf implant temporarily fills cartilage defects before gradually resorbing as surrounding tissue regenerates. Long-term MRI findings and peer-reviewed Phase II clinical data have provided evidence of cartilage maturation and durable structural repair, while the company has reported greater pain improvement than traditional microfracture. Regentis has treated 43 of 80 planned patients in its U.S. pivotal Phase III trial, with enrollment expected to conclude around the end of 2026, and is preparing for…

Continue Reading

TuesdayOct 20, 2026 11:48 am

QualityStocksNewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Targets $3 Million in Additional Annualized Operating Expense Reductions 

Beeline Holdings (NASDAQ: BLNE), a digital mortgage and home equity platform, announced an additional operating expense reduction plan targeting approximately $250,000 in monthly savings, or $3 million annually, beyond cost reductions implemented earlier in 2026. The initiative includes workforce reductions, infrastructure consolidation and elimination of legacy overhead costs, with approximately $270,000 in one-time transition expenses expected through Dec. 1, 2026. The company anticipates realizing the full monthly savings thereafter, supporting its efforts to improve operating leverage and accelerate its path toward positive operating cash flow. Beeline continues to leverage its MagicBlocks AI customer acquisition technology and new mortgage pricing engine…

Continue Reading

TuesdayOct 20, 2026 11:37 am

QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Completes 1-for-150 Reverse Stock Split to Support Nasdaq Uplisting

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, announced the completion of a 1-for-150 reverse stock split effective Oct. 20, 2026, reducing its outstanding common shares from approximately 543.9 million to 3.6 million. The company's shares began trading on a split-adjusted basis under the temporary symbol NGTFD on Oct. 20 and will revert to NGTF after 20 trading days. The reverse split applies proportionately to all shareholders, with fractional shares rounded up to the next whole share, and does not change the number of authorized shares. The reverse split is intended to increase the per-share trading price and support…

Continue Reading

TuesdayOct 20, 2026 11:20 am

QualityStocksNewsBreaks – TruGolf Holdings, Inc. (NASDAQ: TRUG) Featured in AINewsWire Editorial Highlighting Expansion Into Regulated Asset Tokenization 

TruGolf (NASDAQ: TRUG) was featured in an AINewsWire editorial examining the growing institutional adoption of blockchain technology and the importance of regulatory compliance in tokenized asset markets. The editorial highlights TruGolf's acquisition of Polymath Research Inc. and its Polymesh Layer-1 blockchain, which provides infrastructure for regulated digital securities. Polymath reported more than $132 million in tokenized assets issued on its platform by year-end 2025, with more than 65 active issuers and over 50 ecosystem partners. The editorial also discusses plans to deploy the technology within TruGolf Links Franchising through tokenized equipment leasing and fractional ownership opportunities, along with Polymath's exploration…

Continue Reading

TuesdayOct 20, 2026 10:30 am

TruGolf Holdings Inc. (NASDAQ: TRUG) Completes Polymath Acquisition, Offering Expansion into Institutional Tokenization

The acquisition adds regulated digital-asset infrastructure to TruGolf’s existing golf simulation technology business. Polymath developed Polymesh, a Layer-1 blockchain designed for regulated securities and tokenized real-world assets. As of December 31, 2025, Polymath had issued more than $132 million in tokenized assets for over 65 active issuers. The combined company plans to pursue two complementary businesses: golf simulation technology and institutional tokenization infrastructure. TruGolf Links and Polymath are developing tokenized financing for equipment leasing and fractional franchise ownership, with initiatives targeted for the first quarter of 2027. TruGolf has also appointed Natalie Hirsch as Group CFO and COO, while a…

Continue Reading

TuesdayOct 20, 2026 9:45 am

Nightfood Holdings Inc. (NGTF) Is Bringing Robotics and Semiconductor Manufacturing into a Broader Technology Strategy

Nightfood Holdings is expanding beyond its hospitality robotics roots as it advances initiatives spanning semiconductor equipment, industrial automation and AI-enhanced robotics. The formation of TechForce Advanced Manufacturing creates a pathway to pursue automated wafer sorting and optical inspection opportunities tied to semiconductor production. CEO Jimmy Chan says the company is focused on turning the technology, partnerships and corporate infrastructure it has assembled into tangible operational achievements and commercial progress. Artificial intelligence is creating opportunities that extend well beyond the software powering it. As demand for computing infrastructure grows, semiconductor manufacturers face increasingly sophisticated production requirements, while businesses across other industries…

Continue Reading

TuesdayOct 20, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline

VERAXA is implementing FDA-aligned New Approach Methodologies (“NAMs”) across its preclinical research programs, aiming to improve the relevance of experimental findings to human biology while reducing animal testing. The strategy supports development of the company’s BiTAC(R) T-cell engagers, BiTAC-based antibody-drug conjugates and bispecific antibody-drug conjugates for the treatment of cancer. New three-dimensional spheroid data reportedly reinforce the ability of VERAXA’s models to assess the dual-target specificity of its lead T-cell engager candidates. An ex vivo study involving 10 low-passage patient-derived xenograft models of non-small cell lung cancer required about 10 mice, compared with an estimated 200 or more for comparable…

Continue Reading

TuesdayOct 20, 2026 9:00 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present AI-Enabled Drug Discovery Keynote at 22nd Drug Discovery Strategic Summit

Oncotelic Therapeutics (OTCQB: OTLC) announced that Chief Business Officer Saran Saund will deliver the opening keynote on the second day of the 22nd Drug Discovery Strategic Summit on Oct. 22, 2026, at 9 a.m. Pacific Time in Millbrae, California. The presentation will explore partition and aggregation as an organizing principle for AI-enabled drug discovery, emphasizing how complex research questions can be divided into focused investigations and findings combined to develop testable hypotheses. Saund will discuss the company's proprietary PDAOAI platform, which indexes approximately 29 million PubMed abstracts, along with its international intellectual property strategy, planned expansion into genetic discovery and…

Continue Reading

MondayOct 19, 2026 3:21 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in Men’s Fitness Article Examining Unbuzzd Clinical Trial Results

Quantum BioPharma (NASDAQ: QNTM) was featured in a Men's Fitness article by Lakshan Weeraratne examining clinical trial results for Unbuzzd, an alcohol recovery formulation developed by Quantum and licensed to Unbuzzd Wellness. The article highlights findings from a company-sponsored, placebo-controlled study involving 26 healthy adults, with 24 completing both treatment sessions. Researchers reported significantly lower estimated blood alcohol concentrations at several time points, improved self-rated alertness and reduced headache severity on certain assessments. Among 17 participants identified as rapid responders, the average percentage decline in estimated blood alcohol during the first 30 minutes was 40.7% greater with Unbuzzd than with…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered